Is There an Interplay between Immune Checkpoint Inhibitors, Thromboprophylactic Treatments and Thromboembolic Events? Mechanisms and Impact in Non-Small Cell Lung Cancer Patients

PD-1 pathway blockade has been shown to promote proatherogenic T-cell responses and destabilization of atherosclerotic plaques. Moreover, preclinical evidence suggests a potential synergy of antiplatelet drugs with immune checkpoint inhibitors (ICIs). We conducted an analysis within a prospective ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Nichetti, Federico, Ligorio, Francesca, Zattarin, Emma, Signorelli, Diego, Prelaj, Arsela, Proto, Claudia, Galli, Giulia, Marra, Antonio, Apollonio, Giulia, Porcu, Luca, de Braud, Filippo, Lo Russo, Giuseppe, Ferrara, Roberto, Garassino, Marina Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016680/
https://www.ncbi.nlm.nih.gov/pubmed/31881699
http://dx.doi.org/10.3390/cancers12010067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016680/
https://www.ncbi.nlm.nih.gov/pubmed/31881699
http://dx.doi.org/10.3390/cancers12010067

Ejemplares similares